A detailed history of Regions Financial Corp transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Regions Financial Corp holds 20,072 shares of VIRI stock, worth $4,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,072
Previous 20,072 -0.0%
Holding current value
$4,616
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$0.43 - $8.77 $8,630 - $176,031
20,072 New
20,072 $8,000

Others Institutions Holding VIRI

About Virios Therapeutics, Inc.


  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $4.22M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.